Filtered By:
Specialty: Biomedical Science
This page shows you your search results in order of date. This is page number 13.
Order by Relevance | Date
Total 5325 results found since Jan 2013.
The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study
by Sujaree Poopipatpab, Pruchwilai Nuchpramool, Piyarat Phairatwet, Todspol Lertwattanachai, Konlawij Trongtrakul
Patients with mild-to-moderate coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) can be treated with a high-flow nasal cannula (HFNC). The use of the respiratory rate-oxygenation (ROX) index, calculated as the ratio of oxygen saturation (SpO2)/fractional oxygen (FiO2) to respiratory rate, in the first few hours after HFNC initiation can help identify patients who fail HFNC therapy later. However, few studies have documented the use of the ROX index during the period of H...
Source: PLoS One - June 21, 2023 Category: Biomedical Science Authors: Sujaree Poopipatpab Source Type: research
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patient...
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Lanhui Huang Min Liang Yuling He Source Type: research
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | PMC:PMC10279516 | DOI:10.3346/jkms.2023.38.e181
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patient...
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Lanhui Huang Min Liang Yuling He Source Type: research
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | PMC:PMC10279516 | DOI:10.3346/jkms.2023.38.e181
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patient...
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Lanhui Huang Min Liang Yuling He Source Type: research
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | PMC:PMC10279516 | DOI:10.3346/jkms.2023.38.e181
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patient...
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Lanhui Huang Min Liang Yuling He Source Type: research
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | DOI:10.3346/jkms.2023.38.e181
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research
New-Onset Fulminant Type 1 Diabetes Following SARS-CoV-2 Protein Subunit Vaccine: A Case Report and Literature Review
We report a rare case of a 39-year-old woman who suffered from severe hyperglycemia and ketoacidosis with normal hemoglobin A1c four days after SARS-CoV-2 protein subunit vaccine, which is consistent with the diagnosis of fulminant type 1 diabetes (FT1D). She received insulin therapy and recovered after 24 days from onset of the symptoms. This is the first case of new-onset FT1D after SARS-CoV-2 protein subunit vaccination and one of only six that developed after any form of SARS-CoV-2 vaccination. We hope to raise awareness of this potential adverse consequence and recommend careful monitoring after vaccination in patient...
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Lanhui Huang Min Liang Yuling He Source Type: research
Comparison of Clinical Manifestations of Kawasaki Disease According to SARS-CoV-2 Antibody Positivity
CONCLUSION: High incidence of intravenous immunoglobulin-refractory KD may occur in up to 40% of the patients having recent history of coronavirus disease 2019. For patients having KD with N-type SARS-CoV-2 antibody positivity, adjunctive treatment, such as corticosteroids, can be considered as the first line of treatment.PMID:37337806 | PMC:PMC10279516 | DOI:10.3346/jkms.2023.38.e181
Source: Journal of Korean Medical Science - June 20, 2023 Category: Biomedical Science Authors: Jin Ho Kim Jihye You Source Type: research
Trends of humoral immune responses to heterologous antigenic exposure due to vaccination & amp; omicron SARS-CoV-2 infection: Implications for boosting
CONCLUSIONS: Anti-RBD IgG antibodies were detected in 85 per cent of participants after a median gap of eight months following the second vaccine dose. Omicron infection probably resulted in a substantial proportion of asymptomatic infection in the first four months in our study population and boosted the vaccine-induced humoral immune response, which declined but still remained durable over 10 months.PMID:37322634 | DOI:10.4103/ijmr.ijmr_2521_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Gaurav Batra Deepika Rathna Murugesan Sreevatsan Raghavan Souvick Chattopadhyay Farha Mehdi None Ayushi Mudita Gosain Savita Singh Soon Jyoti Das Suprit Deshpande Sudipta Sonar Kamini Jakhar Jayanta Bhattacharya Shailendra Mani Anil Kumar Pandey None Sank Source Type: research
Risk factors for clinically significant diffuse parenchymal lung abnormalities persisting after severe COVID-19 pneumonia
CONCLUSIONS: Longer hospital stay was observed to be the only independent predictor of CS-DPLA six months after severe COVID-19. Serum TGF-β should be evaluated further as a biomarker.PMID:37322633 | DOI:10.4103/ijmr.ijmr_2360_22
Source: The Indian Journal of Medical Research - June 16, 2023 Category: Biomedical Science Authors: Sahajal Dhooria Siddhant Arora Shivani Chaudhary Inderpaul Singh Sehgal Nidhi Prabhakar Nasim Mohammad Riya Sharma Prabir Das Yashwant Kumar Mandeep Garg Goverdhan Dutt Puri Ashish Bhalla Valliappan Muthu Kuruswamy Thurai Prasad Ritesh Agarwal Ashutosh Na Source Type: research
